EDAP TMS S.A. Cost of Revenue 2011-2026 | EDAP

Cost of Revenue is a financial metric that reflects all direct costs associated with the production of goods or the provision of services that directly led to revenue during the reporting period. It is the total amount of expenses incurred by the company to deliver its products or services, including both production costs and related expenses necessary for delivery or customer support.

What is included in the cost of revenue

Cost Category	Examples
Production Costs	Materials, wages of production staff, depreciation of equipment
Service and Support	Customer service, user support, technical assistance
Delivery and Logistics	Packaging, delivery of goods to customers
Hosting and Infrastructure	Servers, cloud platforms (especially for IT and SaaS companies)
Content and Licenses	License purchases, production royalties (e.g., in streaming services)

Importance of the Metric

Helps to understand how costly the revenue-generating process is.
A high cost of revenue may indicate:
Poor cost control
Low operational efficiency
A low cost of revenue combined with high revenue indicates high profitability and business competitiveness.

Annual Cost of Revenue EDAP TMS S.A.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
37.6 M	36 M	30.9 M	25.6 M	23.3 M	23.9 M	22.3 M	20.9 M	19.2 M	18.5 M	15.6 M	14.8 M	15.6 M	13.4 M

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
37.6 M	13.4 M	22.7 M

Cost of Revenue of other stocks in the Medical devices industry

Issuer	Cost of Revenue	Price	% 24h	Market Cap	Country
Acutus Medical AFIB	10.3 M	-	-26.83 %	$ 2.62 M	USA
LivaNova PLC LIVN	448 M	$ 69.84	1.14 %	$ 3.79 B	Britain
Allied Healthcare Products AHPI	24.5 M	-	3.58 %	$ 2.21 M	USA
Cognyte Software Ltd. CGNT	104 M	$ 6.61	3.44 %	$ 475 M	Israel
Apollo Endosurgery APEN	34.4 M	-	-	$ 475 M	USA
Alphatec Holdings ATEC	232 M	$ 13.85	-0.57 %	$ 2.08 B	USA
Avinger AVGR	5.65 M	-	-20.74 %	$ 369 K	USA
AxoGen AXGN	57.9 M	$ 31.25	-3.85 %	$ 1.44 B	USA
Axonics Modulation Technologies AXNX	76 M	-	-	$ 3.31 B	USA
Aziyo Biologics AZYO	13.7 M	-	1.37 %	$ 20.5 M	USA
Apyx Medical Corporation APYX	18.6 M	$ 3.46	-2.26 %	$ 120 M	USA
Conformis CFMS	38.8 M	-	-	$ 16.4 M	USA
Bio-Rad Laboratories BIO	1.19 B	$ 269.55	0.25 %	$ 7.61 B	USA
BIOLASE BIOL	32.4 M	-	-13.19 %	$ 166 K	USA
Bruker Corporation BRKR	1.72 B	$ 39.92	0.38 %	$ 5.95 K	USA
BioSig Technologies BSGM	57 K	-	37.08 %	$ 85.7 M	USA
Boston Scientific Corporation BSX	6.22 B	$ 74.02	-1.5 %	$ 110 B	USA
ClearPoint Neuro CLPT	12.3 M	$ 15.18	4.3 %	$ 410 M	USA
CONMED Corporation CNMD	624 M	$ 46.01	-0.07 %	$ 1.43 B	USA
Cardiovascular Systems CSII	63.4 M	-	0.15 %	$ 844 M	USA
Neovasc NVCN	556 K	-	-	$ 111 M	Canada
InMode Ltd. INMD	79.5 M	$ 13.96	-0.14 %	$ 902 M	Israel
Cutera CUTR	171 M	-	-10.19 %	$ 1.99 M	USA
Delcath Systems DCTH	6.19 M	$ 10.16	2.11 %	$ 290 M	USA
Dynatronics Corporation DYNT	21.4 M	-	14.99 %	$ 929 K	USA
Eargo EAR	23 M	-	-	$ 10.2 M	USA
Electromed ELMD	14 M	$ 23.53	1.64 %	$ 199 M	USA
Second Sight Medical Products EYES	11.8 M	-	-0.97 %	$ 54.4 M	USA
Establishment Labs Holdings ESTA	56.5 M	$ 77.39	-2.87 %	$ 2.18 B	Costa-rica
Nano-X Imaging Ltd. NNOX	21.9 M	$ 2.46	1.23 %	$ 144 M	Israel
GBS GBS	1.81 M	-	-0.57 %	$ 7.12 M	USA
Globus Medical GMED	958 M	$ 95.57	3.99 %	$ 12.9 B	USA
Profound Medical Corp. PROF	3.92 M	$ 7.35	2.79 %	$ 180 M	Canada
Helius Medical Technologies HSDT	583 K	$ 2.18	17.84 %	$ 1.33 M	USA
IRadimed Corporation IRMD	16.9 M	$ 100.38	1.3 %	$ 1.27 B	USA
Invacare Corporation IVC	566 M	-	-	$ 24.7 M	USA
Integra LifeSciences Holdings Corporation IART	728 M	$ 11.54	0.09 %	$ 889 M	USA
Inogen INGN	181 M	$ 6.07	3.94 %	$ 144 M	USA